Therapy Response

Provide Data-Informed Therapy Response and Automated Protocol Management

HealthMyne provides tools for documenting treatment response, ensuring appropriate protocol assignment and efficiently tracking patients.

  • Optimize clinical results and improve patient treatment
  • Improve patient retention on trial protocols
  • Incorporate radiomic data for use in trials management
  • Potential to increase trial availability
  • Leverage multidisciplinary collaboration for patient recruitment
  • Meet sponsor protocol and reporting requirements
  • Achieve a quick return on investment through patient retention and more efficient management

Designed for patients on clinical trials or for patient populations where a standardized assessment is desired. The Therapy Response module allows clinical trial administrators and the multidisciplinary care team to track patients as they progress through treatment. In addition, therapy response reports are easily generated allowing for critical data aggregation, collaboration and dissemination of accurate response assessment detail and required protocol criteria.

Standard therapy response assessments such as RECIST v1.1, mRECIST, mRECIST for MPM, CHOI, EASL, irRC, irRECIST, PERCIST, iRECIST, WHO, RANO, Lugano, and MacDonald are incorporated or create customized protocols specific to your trial management needs.

Emerging data supports the incorporation of radiomic insights to inform decision-making, trial management, prediction of therapy/treatment response, recurrence, and survival. HealthMyne makes it easy to access radiomic information — such as volume, texture, doubling time, GGO percentage, and more — from patient’s participating in clinical trials.

Consistent tumor analysis, access to novel imaging data, and a more efficient workflow advance therapy response with clinical trials.

Novel imaging-based biomarkers — radiomic features and clinical signatures — can potentially reveal critical information earlier than standard metrics such as the change in the longest dimension of a tumor. HealthMyne AI-enabled radiomic workflow solutions allow researchers and clinicians to monitor disease evolution, evaluate treatment efficacy, and predict therapeutic outcomes.

Read More

Analyze Real World Evidence of Therapy Response

  • Inform patient inclusion and cohort selection
  • Improve patient retention on clinical trial protocols
  • Potential to increase trial availability
  • Incorporate and automate trial protocol and reporting requirements
  • Measure radiomic data and response to therapy over time

Learn more about radiomic informed clinical trials and therapy response